Kennedy Lishimpi and Emily Fitzgerald
2024年11月21日
A revolutionary new implant has demonstrated remarkable success in restoring mobility to a Parkinson's patient who had been paralyzed. This groundbreaking device features a neurostimulator strategically positioned against the spinal cord and a complementary device embedded beneath the skin of the abdomen. Working in tandem, these components deliver precise electrical impulses to the spine, effectively mimicking the natural activation patterns that occur during walking.
Parkinson's patient Marc Gaulthier, 63, courageously volunteered to participate in an experimental trial involving this innovative implant. Prior to the procedure, Marc's mobility was severely impaired, confining him to his home. However, following the implantation, Marc experienced a remarkable transformation, regaining the ability to walk and reclaim his independence.
Parkinson's disease is a progressive neurological disorder characterized by a constellation of symptoms, including tremors, rigidity, and coordination difficulties. Currently affecting approximately 8.5 million individuals worldwide, Parkinson's prevalence has doubled over the past two and a half decades.
Marc's neuroprosthetic device was meticulously designed by Onward Medical, a company aiming to make this life-changing technology widely accessible by 2026. In a significant step forward, the Swiss research center NeuroRestore is poised to conduct clinical trials involving six additional patients, further evaluating the efficacy of this revolutionary treatment approach.